Plain-English translation of NCT07648355 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new intraocular lens implant called Clareon TruPlus that is placed in your eye during cataract surgery. Researchers want to see how well this lens helps you see after surgery and how satisfied you are with your vision. You'll be followed for up to 3 months after your surgery to measure your vision and gather your feedback.
Cataract surgery is very common, but doctors are always looking for better lens implants that can help patients achieve the clearest vision possible. This study will help determine how well this new lens performs in real patients like you.
You likely qualify if…
You likely don't qualify if…
You will receive cataract surgery with the new Clareon TruPlus lens implant at a single clinic location. After surgery, you'll return for follow-up visits over the next 3 months, during which doctors will test your vision, measure how well your eye is healing, and ask you questions about your satisfaction with your vision through a questionnaire. The study involves standard post-surgery care and evaluation.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
United States
Collaborators
Sengi
Enrollment target
~40 participants
Started
June 2026
Primary completion
July 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ashley Prepeluh
OVO Lasik and Lens LLC
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.